DEVELOPMENTAL FUNDS

发展基金

• 批准号: 7944866
• 负责人: BRIAN LEYLAND-JONES
• 金额: $ 13.41万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-07 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7944866
• 关键词: ARHGEF5 gene; Address; Area; Bioinformatics; Biological Markers; Breast; Cancer Center; Cancer Center Support Grant; Characteristics; Clinical Trials; Core Facility; Detection; Development; Feedback; Funding; Future; Gene Targeting; Grant; Institutes; Lung; Malignant Neoplasms; Methodology; Mus; Nanotechnology; Organ; Phase; Physicians; Process; Research; Research Personnel; Resources; Scientist; Site; Strategic Planning; Testing; Therapeutic; Transgenic Mice; Translation Process; Translations; Universities; cancer imaging; cohort; health disparity; human subject; malignant breast neoplasm; new technology; oncology; population based; programs; success

Overall Description. As part of the P20 Planning Grant period, key areas of development in the Winship Cancer Institute were identified as part of the strategic planning process. Some major strategic initiatives included: 1) recruitment of researchers and physician-scientists in designated fields of expertise; 2) developmental scientific programs in Breast Cancer and Lung-Aerodigestive Cancers; and 3) two developmental shared core resources - Bioinformatics and Transgenic Mouse and Gene Targeting cores. The successful recruitment of 88 new scientists and clinicians to the WCI in the past five years has largely addressed the first aim. These recruitments are noted in greater detail in "6.0 Six Essential Characteristics of the Cancer Center" and the scientific program areas. The reconfiguration of the WCI scientific programs toward over-arching and uniting themes rather than a focus on organ-site programs has moved the WCI away from previous plans intended to set up the developmental programs in Breast and Lung-Aerodigestive cancers. Third, the need for development of new technologies, such as bioinformatics, and shared core resources remains vital to the future success and advancement of the Winship Cancer Institute. Thus, the Developmental funds as part of the CCSG are being allocated in support of two components: 1) support of new technology and methodologies in Cancer Bioinformatics. and 2) development of a new shared core resource: the Transqenic Mouse and Gene Targeting Core.

总体描述。作为P20规划补助金期间的一部分， 温希普癌症研究所被确定为战略规划过程的一部分。一些 主要的战略举措包括： 1)招聘指定专业领域的研究人员和医生-科学家; 2)乳腺癌和肺呼吸消化道癌症的发展科学计划;以及 3)两个发展共享的核心资源-生物信息学和转基因小鼠和基因 瞄准核心 在过去五年中，WCI成功招募了88名新的科学家和临床医生， 多年来，主要是为了实现第一个目标。这些征聘的详细情况见“6.0 癌症中心的六个基本特征”和科学计划领域。的 重新配置WCI的科学计划，使其过度融合和统一主题， 比对器官网站计划的关注已经使WCI远离了以前的计划， 建立乳腺癌和肺癌的发展计划。第三，需要 开发生物信息学等新技术和共享核心资源 对于Winship癌症研究所未来的成功和进步仍然至关重要。因此 发展资金作为CCSG的一部分，正在分配用于支持两个组成部分： 支持癌症生物信息学新技术和方法。（2）发展 一个新的共享核心资源：转基因小鼠和基因靶向核心。